Loading...
MBRX MOLECULIN BIOTECH INC Business Restructuring 8-K Filing
Back
MLCL
MBRX
MOLECULIN BIOTECH INC
(MBRX)
Follow
FY2023 8 K
View More
Back
MLCL
MBRX
MOLECULIN BIOTECH INC
(MBRX)
Follow
FY2023 8 K
Filing:
8 K
Published on:
21 Aug '23
Meetings
25 Apr '25
Investor Presentation
21 Apr '25
Conference Presentation
17 Apr '25
Meeting Adjournment
9 Apr '25
Trial Announcement
1 Apr '25
Investor Presentation
24 Mar '25
Financial Results
24 Mar '25
Patent Announcement
6 Mar '25
Capital Raise
26 Feb '25
Warrant Agreement
13 Feb '25
FDA Guidance Received
13 Feb '25
Regulatory Approval
11 Feb '25
Warrant Adjustment
10 Feb '25
Investor Call Update
27 Jan '25
Investor Call
27 Jan '25
Investor Update
27 Jan '25
Business Outlook
8 Jan '25
Investor Presentation
8 Jan '25
Investor Presentation
18 Dec '24
Research Publication
11 Dec '24
Research Findings
18 Nov '24
Corporate Presentation
18 Nov '24
Investor Presentation
14 Nov '24
Clinical Trial Update
14 Nov '24
Trial Approval
12 Nov '24
Corporate Presentation
12 Nov '24
Financial Results
12 Nov '24
Earnings Announcement
5 Nov '24
Annual Meeting Results
25 Oct '24
KOL Event Transcript
17 Oct '24
KOL Event Announcement
7 Oct '24
Investor Presentation
2 Oct '24
Positive Efficacy Data
23 Sep '24
Investor Conference
16 Sep '24
Investor Presentation
16 Sep '24
Clinical Trial Update
9 Sep '24
Public Offering
19 Aug '24
Securities Offering
16 Aug '24
Financial Results
14 Aug '24
Webcast Presentation
6 Aug '24
Press Release
5 Aug '24
Investor Presentation
1 Aug '24
FDA Announcement
1 Aug '24
FDA Meeting Announcement
10 Jul '24
Presentation
18 Jun '24
Clinical Trial Update
14 Jun '24
Announcement
16 May '24
Phase 2 Study Commencement
15 May '24
Presentation
14 May '24
Filing Correction
13 May '24
Earnings Reports
13 May '24
Patent Notification
9 May '24
Earnings Calls
8 May '24
Corporate Presentation
7 May '24
Announcement of Positive In...
7 May '24
AML Clinical Day
2 May '24
Investor Presentation
25 Apr '24
Product Launch
18 Apr '24
8-K Filing
10 Apr '24
Compliance with Bid Price Rule
8 Apr '24
Patent Notification
27 Mar '24
Presentation
25 Mar '24
Press Release
25 Mar '24
Financial Results Announcement
22 Mar '24
Earnings Calls
20 Mar '24
Reverse Stock Split
19 Mar '24
Investor Call
29 Feb '24
Investor Call
22 Feb '24
Investor Call
15 Feb '24
Investor Presentation
14 Feb '24
Meeting Results
14 Feb '24
Press Release
24 Jan '24
Management Changes
5 Jan '24
Securities Purchase Agreements
21 Dec '23
8-K Filing
18 Dec '23
Investor Presentation
11 Dec '23
Press Release
11 Dec '23
Investor Call
20 Nov '23
Press Release
13 Nov '23
Earnings Reports
13 Nov '23
Earnings Reports
7 Nov '23
Clinical Trial Results
6 Nov '23
Delisting Extension
3 Nov '23
Earnings Calls
17 Oct '23
Special Meeting of Stockhol...
6 Oct '23
Clinical Trial Completion
21 Sep '23
Press Release
18 Sep '23
Announcement
14 Sep '23
Bylaws Amendment
21 Aug '23
Investor Presentation
21 Aug '23
Financial Results Announcement
11 Aug '23
Press Release
10 Aug '23
Investigation of Short Selling
7 Aug '23
Earnings Reports
3 Aug '23
Conference Presentation
13 Jun '23
Annual Meeting of Stockholders
26 May '23
Disclosure
12 May '23
Earnings Reports
11 May '23
Press Release
10 May '23
Delisting
5 May '23
External Links:
SEC
AI Assistant
Close
MOLECULIN BIOTECH INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.